Clinical Trial Update: Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating a dendritic cell–based tumor vaccine as adjuvant immunotherapy for glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Dendritic cell-based tumor vaccine adjuvant immunotherapy

Snippet

Sponsor: China Medical University Hospital | Conditions: Glioblastoma Multiforme, Glioblastoma | Phase 2 | Status: UNKNOWN